NEW YORK — AusDiagnostics said on Monday that it has received CE marking for its multiplex PCR assay for SARS-CoV2, influenza, and respiratory syncytial virus (RSV).
The firm also said that the panel has been included in the Australian Register of Therapeutic Goods.